Nyxoah (NASDAQ:NYXH – Get Free Report) will likely be posting its quarterly earnings results after the market closes on Thursday, March 13th. Analysts expect Nyxoah to post earnings of ($0.46) per share and revenue of $2.02 million for the quarter.
Nyxoah Trading Up 3.3 %
Nyxoah stock opened at $9.95 on Wednesday. The firm has a 50-day moving average of $10.21 and a 200-day moving average of $9.16. Nyxoah has a one year low of $6.76 and a one year high of $20.00. The company has a debt-to-equity ratio of 0.21, a current ratio of 5.28 and a quick ratio of 4.95. The company has a market cap of $338.90 million, a price-to-earnings ratio of -5.32 and a beta of 1.42.
Analyst Ratings Changes
Separately, HC Wainwright reiterated a “buy” rating and issued a $17.00 target price on shares of Nyxoah in a research note on Friday, December 13th.
Nyxoah Company Profile
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.
See Also
- Five stocks we like better than Nyxoah
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- 3 Stocks to Consider Buying in October
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- What is a Special Dividend?
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Nyxoah Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nyxoah and related companies with MarketBeat.com's FREE daily email newsletter.
